Skip to main content

Table 2 Distribution of genotype and allele among OA patients and controls

From: The association between ADAM12 gene polymorphisms and osteoarthritis: an updated meta-analysis

Study author

Sex

Patient group

Control group

P-HWE

MAF

GG

GC

CC

G

C

GG

GC

CC

G

C

Rs3740199

Kerna [37]a

Male

2

7

6

11

19

4

15

16

23

47

0.87

0.67

Female

4

25

22

33

69

8

31

49

47

129

0.35

0.73

Kerna [37]b

Male

1

8

16

10

40

5

13

7

23

27

0.82

0.54

Female

9

26

37

34

100

3

30

34

36

98

0.25

0.73

Shin [38]

Male

45

94

32

184

158

281

423

178

985

779

0.41

0.44

Female

169

270

115

608

500

243

440

172

926

784

0.29

0.46

Poonpet [41]

Male/Female

42

102

56

186

214

54

100

46

208

192

0.98

0.48

Wang [25]

Male/Female

44

84

36

172

156

51

102

47

204

196

0.77

0.50

Lou [39]

Male/Female

42

78

32

162

142

44

93

42

181

177

0.60

0.50

Haberal [5]

Male/Female

51

76

23

178

122

38

78

34

154

146

0.62

0.49

Aguilar [42]

Male/Female

58

45

29

161

103

67

76

21

210

118

0.94

0.36

Rodriguez-Lopez [40]*

Male/Female

NA

NA

NA

234

290

NA

NA

NA

261

327

NA

0.44

Rodriguez-Lopez [40]*

Male/Female

NA

NA

NA

350

370

NA

NA

NA

652

744

NA

0.47

Rodriguez-Lopez [40]*

Male/Female

NA

NA

NA

138

180

NA

NA

NA

147

239

NA

0.38

Study author

Sex

Patient group

Control group

P-HWE

MAF

TT

TC

CC

T

C

TT

TC

CC

T

C

Rs1871054

Lou [39]

Male/Female

26

57

69

109

195

47

88

44

182

176

0.83

0.50

Wang [25]

Male/Female

29

59

76

117

211

52

99

49

203

197

0.89

0.49

Haberal [5]

Male/Female

43

67

40

153

147

41

70

39

152

148

0.41

0.49

Aguilar [42]

Male/Female

24

76

32

124

140

21

90

53

132

196

0.07

0.60

Kerna [37]a

Male

4

8

3

16

14

10

17

8

37

33

0.88

0.47

Female

14

25

12

53

49

20

45

23

85

91

0.82

0.52

Kerna [37]b

Male

7

11

7

25

25

7

14

4

28

22

0.50

0.44

Female

17

35

20

69

75

17

35

15

69

65

0.71

0.49

Kerna [26]

Male

3

7

10

13

27

14

29

8

57

45

0.27

0.45

Kerna [26]a

Male

2

3

8

7

19

19

35

12

73

59

0.55

0.55

Fatima [24]

Male

35

37

26

107

89

35

41

24

447

353

0.09

0.45

Female

71

153

88

295

329

97

142

61

336

264

0.49

0.44

Study author

Sex

Patient group

Control group

P-HWE

MAF

GG

GA

AA

G

A

GG

GA

AA

G

A

Rs1278279

Wang [25]

Male/Female

92

62

10

264

82

121

64

15

306

94

0.12

0.24

Lou [39]

Male/Female

84

59

9

238

77

106

60

13

272

86

0.27

0.24

Study author

Sex

Patient group

Control group

P-HWE

MAF

TT

TC

CC

T

C

TT

TC

CC

T

C

Rs1044122

Wang [25]

Male/Female

51

88

25

190

138

62

101

37

225

175

0.71

0.44

Lou [39]

Male/Female

47

81

24

129

175

56

92

31

204

154

0.52

0.43

Kerna [26]

Male

21

27

6

69

39

29

27

10

85

47

0.38

0.37

Female

58

65

8

181

81

53

66

24

172

114

0.66

0.40

Fatima [24]

Male

40

39

9

119

57

53

39

8

145

55

0.83

0.28

Female

125

144

46

394

236

172

102

26

446

154

0.06

0.27

  1. P-HWE P-value for Hardy–Weinberg equilibrium; MAF Minor allele frequency of control group; NA Data not available
  2. a: tibiofemoral knee OA; b: patellofemoral knee OA; *: An independent study in one article